UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): October 31, 2017
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
|
UTAH
|
87‑0342734
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
|
Registrant's telephone number:
|
(801) 566‑1200
|
On October 31, 2017, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.27 per share is payable on January 3, 2018 to shareholders of record at the close of business on December 15, 2017. A copy of the press release is attached hereto as Exhibit 99.1
EXHIBIT INDEX
|
Index
|
|
|
Number
|
Description
|
| |
|
|
99.1
|
Press release issued October 31, 2017: Utah Medical Products, Inc. Increases Quarterly Dividend
|
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
UTAH MEDICAL PRODUCTS, INC.
|
| |
REGISTRANT
|
| |
|
| |
|
|
Date: 10/31/2017
|
By:/s/ Kevin L. Cornwell
|
| |
Kevin L. Cornwell
|
| |
CEO
|